Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492
Benzinga Newsdesk 6 days ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $473 to $492.
Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $473 to $492.